Prosecution Insights
Last updated: April 19, 2026

Examiner: OLYNICK, DAVID

Tech Center 3700 • Art Units: 3741

This examiner grants 78% of resolved cases

Performance Statistics

78.3%
Allow Rate
+8.3% vs TC avg
246
Total Applications
+25.2%
Interview Lift
790
Avg Prosecution Days
Based on 226 resolved cases, 2023–2026

Rejection Statute Breakdown

0.6%
§101 Eligibility
21.3%
§102 Novelty
50.2%
§103 Obviousness
24.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19139120 METHOD FOR MANAGING POWER TRANSITIONS BETWEEN A GENERATION MODE AND AN ASSISTANCE MODE Non-Final OA SAFRAN
19040565 TURBINE ENGINE INCLUDING A STEAM SYSTEM Non-Final OA General Electric Company
19099468 EXHAUST SYSTEM FOR A TURBINE ENGINE, COMPRISING A HEAT EXCHANGER Non-Final OA SAFRAN NACELLES
19102089 FUEL GAS BOOSTER-GAS TURBINE INTEGRATION FOR ENERGY SAVING & OPTIMIZED OPERABILITY Non-Final OA NUOVO PIGNONE TECNOLOGIE - S.R.L.
18578214 An Injection Support Pad Non-Final OA SHL Medical AG
18478552 INFUSION PUMP WITH MULTI-CGM COMPATIBILITY Non-Final OA Tandem Diabetes Care, Inc.
18927784 HYBRID TURBOFAN ENGINE WITH A PLANETARY GEARSET FOR BLENDING POWER BETWEEN AN ELECTRIC OUTPUT AND VARIABLE-THRUST BYPASS FAN Final Rejection VerdeGo Aero, Inc.
18575775 Direct Fluid Path for Inline Dual Lumen Port Non-Final OA Bard Peripheral Vascular, Inc.
18286982 AN ASSEMBLY FOR AN INJECTION DEVICE Non-Final OA West Pharmaceutical Services, Inc.
18131460 CONTROL SAFEGUARDS FOR INFUSION PUMP Non-Final OA B. Braun Medical Inc.
18123720 CRADLE FOR AN INFUSION PUMP Non-Final OA B. Braun Medical Inc.
18139156 INTRANASAL DEVICE FOR AUTOMATIC OPIOID OVERDOSE DETECTION AND NALOXONE DELIVERY Non-Final OA QuikReversal LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month